Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study

被引:29
|
作者
Langade, Deepak [1 ]
Thakare, Vaishali [1 ]
Kanchi, Subodh [2 ]
Kelgane, Sunil [3 ]
机构
[1] DY Patil Univ, Sch Med, Navi Mumbai 400706, Maharashtra, India
[2] NAMO Med Educ & Res Inst, Silvassa, Dnh & Dd, India
[3] Maharashtra Emergency Med Serv, Pimpri Chinchwad 411027, Maharashtra, India
关键词
Insomnia; Anxiety; Ashwagandha; Sleep onset latency; Actigraphy; Herbal medicine; WITHANIA-SOMNIFERA; GABA(A) RECEPTORS; AMERICAN-ACADEMY; EFFICACY; MEDICINE; STRESS; SAFETY; ACTIGRAPHY; MANAGEMENT; DISORDERS;
D O I
10.1016/j.jep.2020.113276
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Ashwagandha (Withania somnifera (L.) Dunal.) is long known for its sleepinducing effects. Ashwagandha can be proposed as an alternative to the recommended present treatments for insomnia. This study aimed to evaluate the pharmacological effect of Ashwagandha root extract on sleep in healthy subjects and also in the subjects having insomnia. Material and methods: We performed a randomized, parallel-group, stratified design, placebo-controlled study. A total of 80 eligible participants, 40 in Arm-A (healthy) and 40 in Arm-B (insomnia) were assigned to two groups, either Ashwagandha or placebo and studied for 8-weeks. The assessment was done based on the sleep parameters (Sleep Onset Latency, Total Sleep Time, Wake After Sleep Onset, Total time in bed, and Sleep Efficiency), Pittsburgh Sleep Quality Index and Hamilton Anxiety scale-A questionnaire, mental alertness on rising assessment, and sleep quality questionnaire. Safety and adverse events along with the concomitant medication were also assessed. Results: In both healthy and insomnia subjects, there was a significant improvement in the sleep parameters in the Ashwagandha mot extract supplemented group. The improvement was found more significant in insomnia subjects than healthy subjects. Repeat measure Analysis of variance (ANOVA) confirmed the significant improvement in SOL (p 0.013), HAM-A outcomes (p < 0.05), mental alertness (p 0.01), and sleep quality (p < 0.05) of the insomnia patients. A two-way ANOVA was used to confirm the outcomes that denoted sleep onset latency (p < 0.0001) and sleep efficiency (p < 0.0001) as the most improved parameters, followed by TST (p < 0.002) and WASO(p < 0.040). All these parameters (SOL, TST, WASO, TIB, SE, PSQI, HAM-A, Mental Alertness, and Sleep quality) were also statistically assessed for the significant improvement within the group both for the treatment, and the placebo groups in the healthy and the insomnia datasets. Obtained results suggest statistically significant (p < 0.0001) changes between the baseline values and the end of the study results except for the HAM-A and the mental alertness scoresn the healthy subject group. Conclusion: The present study confirms that Ashwagandha root extract can improve sleep quality and can help in managing insomnia. Ashwagandha root extract was well tolerated by all the participants irrespective of their health condition and age. Additional clinical trials are required to generalize the outcome.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial
    Jahanbakhsh, Seyedeh Pardis
    Manteghi, Ali Akhondpour
    Emami, Seyed Ahmad
    Mahyari, Saman
    Gholampour, Beheshteh
    Mohammadpour, Amir Hooshang
    Sahebkar, Amirhossein
    COMPLEMENTARY THERAPIES IN MEDICINE, 2016, 27 : 25 - 29
  • [22] The reduction impact of monoglucosyl rutin on abdominal visceral fat: A randomized, placebo-controlled, double-blind, parallel-group
    Hashizume, Yushi
    Tandia, Mahamadou
    JOURNAL OF FOOD SCIENCE, 2020, 85 (10) : 3577 - 3589
  • [23] Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study
    Lieberman, A
    Ranhosky, A
    Korts, D
    NEUROLOGY, 1997, 49 (01) : 162 - 168
  • [24] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Pasquale Caponnetto
    Davide Campagna
    Jasjit S. Ahluwalia
    Christopher Russell
    Marilena Maglia
    Paolo Marco Riela
    Carmelo Fabio Longo
    Barbara Busa
    Riccardo Polosa
    BMC Medicine, 21
  • [25] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Caponnetto, Pasquale
    Campagna, Davide
    Ahluwalia, Jasjit S.
    Russell, Christopher
    Maglia, Marilena
    Riela, Paolo Marco
    Longo, Carmelo Fabio
    Busa, Barbara
    Polosa, Riccardo
    BMC MEDICINE, 2023, 21 (01)
  • [26] Efficacy and Safety of Dietary Undenatured Type II Collagen on Joint and Motor Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
    Shiojima, Yoshiaki
    Takahashi, Megumi
    Takahashi, Ryohei
    Maruyama, Kazuo
    Moriyama, Hiroyoshi
    Bagchi, Debasis
    Bagchi, Manashi
    Akanuma, Masanori
    JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION, 2023, 42 (03): : 224 - 241
  • [27] Treatment of partial seizures with gabapentin: Double-blind, placebo-controlled, parallel-group study
    Yamauchi, Toshio
    Kaneko, Sunao
    Yagi, Kazuichi
    Sase, Shinichi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (04) : 507 - 515
  • [28] Effects of Chlorogenic Acids on Menopausal Symptoms in Healthy Women: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Trial
    Enokuchi, Yuka
    Suzuki, Atsushi
    Yamaguchi, Tohru
    Ochiai, Ryuji
    Terauchi, Masakazu
    Kataoka, Kiyoshi
    NUTRIENTS, 2020, 12 (12) : 1 - 12
  • [29] A double-blind, placebo-controlled, parallel-group study to assess the effects of pregabalin on reproductive function in healthy males
    Morrell, M
    Brigell, M
    Chartier, K
    Barrett, JA
    NEUROLOGY, 2004, 62 (07) : A314 - A314
  • [30] A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers
    van Nispen, CHM
    Hoepelman, AIM
    Rozenberg-Arska, M
    Verhoef, J
    Purkins, L
    Willavize, SA
    AMERICAN JOURNAL OF SURGERY, 1998, 176 (06): : 27S - 31S